Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Foresight Diagnostics Logo
Foresight Diagnostics Growth Score
54
CB Rank
84695
Heat Score
36
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Acquired by
Natera Logo
Natera
Founded
obfuscation
PrivateSeries B Denver, Colorado, United States11-50 www.foresight-dx.com
Biotechnology
Health Care
Pharmaceutical
Overview

Foresight Diagnostics
Total Funding
obfuscation
Growth Score
54
Heat Score
36

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score54
-8 pts
in past quarter
Heat Score 36
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Foresight Diagnostics

CB Rank
84695
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Acquired by
Natera Logo
Natera
Founded
obfuscation
PrivateSeries B Denver, Colorado, United States11-50 www.foresight-dx.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Sub-Organization of 
Natera Logo
Natera
Legal Name Foresight Diagnostics Inc.
Operating Status Active
Company Type For Profit
Founders  Ash Alizadeh, David Kurtz, Jake Chabon, Maximilian Diehn
About the Company
Foresight Diagnostics develops a novel liquid biopsy test for the measurement of minimal residual disease to aid in patient management. They garnered significant partnering interest from multiple pharmaceutical companies in oncology.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Foresight CLARITY™
An ultra-sensitive minimal residual disease (MRD) detection platform using PhasED-Seq™ technology to identify and track tumor-specific phased variants in circulating tumor DNA (ctDNA).
Biopharma Clinical Program Services
Consultative services offering expertise in liquid biopsy, clinical, regulatory, and operational support to develop and accelerate cancer clinical programs and studies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B
obfuscation
Series B - Foresight Diagnostics Logo
Series B - Foresight Diagnostics
7
obfuscation
Foresite CapitalSeries B

Investors

M&A Details

Foresight Diagnostics was acquired by Natera for
obfuscation
on
obfuscation
. This deal was done in Stock.
Transaction Name 
Foresight Diagnostics acquired by Natera Logo
Foresight Diagnostics acquired by Natera
Acquired by 
Natera Logo
Natera
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 7 Board Members and Advisors 3 Contacts 63

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 15, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

5,471
54.68%
 in past month

IT Spend

$148KThis year, Foresight Diagnostics is projected to spend $148K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Human-AI Collaboration Logo
Human-AI Collaboration
95
Machine Ethics Logo
Machine Ethics
90
Capital Injection Logo
Capital Injection
90

Active Website Tech Count

14Foresight Diagnostics is actively using 14 technologies for its website, according to BuiltWith. These include HSTS, DNSSEC, and  Cloudflare CDN.
Sub-Organizations
Frequently Asked Questions

Where is Foresight Diagnostics's headquarters? Foresight Diagnostics is located in Denver, Colorado, United States.Who invested in Foresight Diagnostics? Foresight Diagnostics has 8 investors including Foresite Capital and  Stanford University.When was the last funding round for Foresight Diagnostics? Foresight Diagnostics closed its last funding round on
obfuscation
from a Series B round.Who are Foresight Diagnostics's competitors? Alternatives and possible competitors to Foresight Diagnostics may include Tempus, Element Biosciences, and  SOPHiA GENETICS.How much funding has Foresight Diagnostics raised to date? Foresight Diagnostics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|